TET2 and prostate carcinoma: Previous studies have revealed that TET2 can be a direct target of the Let-7adf cluster in LPS-activated macrophages33, it can be suppressed by miR-29 in prostate cancer cells9, and it is down-regulated by miR-22 in breast cancer cells34.